Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia

Summary

The purpose of this study is to evaluate the efficacy of HSK39297 tablets in paroxysmal nocturnal hemoglobinuria (PNH) patients with anemia after stable treatment of anti-C5 antibody.

Timeline

Start

2025-05-12

Primary completion

2025-12-23

Completion

2026-01-05

Drugs

Indications